ArticleOncoimmunology
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors.
Satyen Harish Gohil et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
pooled itcites it